Oruka Therapeutics Income Statement (2010-2026) | ORKA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating items
Research & Development (Quarter)	3.58M	3.44M	3.94M	2.18M	1.49M	1.02M	0.06M	0.39M	0.25M	0.32M	0.05M	0.17M	0.13M
Selling, General & Administrative (Quarter)	1.26M	1.28M	1.74M	1.10M	1.73M	1.53M	1.49M	1.41M	1.72M	1.61M	1.54M	2.32M	2.99M
Operating Expenses (Quarter)	4.84M	4.72M	5.68M	3.28M	3.22M	2.55M	1.55M	1.80M	1.97M	1.94M	1.59M	2.48M	3.12M
Operating Income (Quarter)	-4.84M	-4.72M	-5.68M	-3.28M	-3.22M	-2.55M	-1.55M	-1.80M	-1.97M	-1.94M	-1.59M	-2.48M	-3.12M
EBIT (Quarter)	-4.84M	-4.72M	-5.68M	-3.28M	-3.22M	-2.55M	-1.55M	-1.80M	-1.97M	-1.94M	-1.59M	-2.48M	-3.12M
Non-operating items
Interest & Investment Income (Quarter)	0.00M	0.00M	0.00M	0.01M	0.07M	0.22M	0.37M	0.45M	0.49M	0.51M	0.50M	0.47M	0.44M
Net income details
EBT (Quarter)	-4.83M	-4.71M	-5.68M	-3.30M	-3.65M	-2.40M	-1.17M	-1.38M	-1.52M	-1.76M	-1.11M	-7.01M	-18.08M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-4.83M	-4.71M	-5.68M	-3.27M	-3.15M	-2.33M	-1.17M	-1.35M	-1.48M	-1.42M	-1.09M	-2.01M	-2.68M
Income from Continuing Operations (Quarter)	-4.83M	-4.71M	-5.68M	-3.30M	-3.65M	-2.40M	-1.17M	-1.38M	-1.52M	-1.76M	-1.11M	-7.01M	-18.08M
Consolidated Net Income (Quarter)	-4.83M	-4.71M	-5.68M	-3.30M	-3.65M	-2.40M	-1.17M	-1.38M	-1.52M	-1.76M	-1.11M	-7.01M	-18.08M
Income towards Parent Company (Quarter)	-4.83M	-4.71M	-5.68M	-3.30M	-3.65M	-2.40M	-1.17M	-1.38M	-1.52M	-1.76M	-1.11M	-7.01M	-18.08M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-4.83M	-4.71M	-5.68M	-3.30M	-3.65M	-2.40M	-1.17M	-1.38M	-1.52M	-1.76M	-1.11M	-7.01M	-18.08M
Additional items
EPS (Basic) (Quarter)	-4.03	-3.92	-4.90	-2.75	-3.04	-1.99	-0.98	-1.15	-1.27	-1.47	-0.93	-5.80	-14.95
EPS (Diluted) (Quarter)	-4.03	-3.92	-4.90	-2.75	-3.04	-1.99	-0.98	-1.15	-1.27	-1.47	-0.93	-5.80	-14.95
Shares Outstanding (Quarter)	1.20M	1.20M	1.16M	1.20M	1.20M	1.20M	1.20M	1.20M	1.20M	1.20M	1.20M	1.21M	1.21M	15.01M	16.79M	41.68M	42.10M	8.82M	9.10M	10.46M
Shares Outstanding (Diluted) (Quarter)	1.20M	1.20M	1.16M	1.20M	1.20M	1.20M	1.20M	1.20M	1.20M	1.20M	1.20M	1.21M	1.21M	15.01M	16.79M	41.68M	42.10M	42.10M	42.10M	42.10M
Shares Outstanding (Entity) (Quarter)
EBITDA (Quarter)	-4.84M	-4.72M	-5.68M	-3.28M	-3.22M	-2.55M	-1.55M	-1.80M	-1.97M	-1.94M	-1.59M	-2.48M	-3.12M
Interest Expenses (Quarter)	0.11M	0.60M	0.07M	0.03M	0.51M	0.07M		0.03M	0.04M	0.34M	0.03M	5.00M	15.40M	21.51M	-32.30M	4.70M	6.63M	30.94M	-14.60M	160.99M
Tax Rate (Quarter)

Research Tools

Developers

Oruka Therapeutics Income Statement (2010-2026) | ORKA

Research Tools

Developers

Oruka Therapeutics Income Statement (2010-2026) | ORKA

Create an account

Sign In

Reset Password